Philip Morris
Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
Fields
- Author
- Burghuber, O.C.
- Punzengruber, C.
- Silberbauer, K.
- Sinzinger, H.
- Punzengruber, C.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- CHAR, CHART, GRAPH, TABLE, MAPS
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Characteristic
- EXTR, EXTRA
- MISS, MISSING PAGES
- Site
- R529
- Named Organization
- Univ of Vienna
- Author (Organization)
- Chest
- Univ of Vienna
- Named Person
- Burghuber, O.C.
- Haber, P.
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- gjc02a00
Document Images
Platelet Sensitivity to Prostacyclin in
Smokers and Non-smokers'`
O: C. BurgFtuber, M.D.; Ch. hunzengruber, M.D.;, H. Sin_inger, 4f.D.;.
P Haber, M.D.; and K Silberbauer M.D.
Platelet activating effect of t:igarettir smoking appears to be
important td the development of adserosckeosis. We previ-
ousfy demonstrated a redlsced sesuitivity of platelets to
- e:ogenosu prostacyclin (PCL) in citro from patients with
proven atherosclerotic tiisease, indicating a possible role of
altered platelet function in the development of atiservsckto-
sis. We now hypothesize that cigarette smokusg might be an
important cause of altered platelet sensitivity to PGLr
observed in patients with at4servsclerosis. To test this hy-
pothesis. the response of platelets to exogenous PGI, was
tested' in chronic smokers and ntm-smokers, prior to and
Smoking has been incriminatedas a pathogenetic fac-
tor in cardiovascular disease."Tobacco smoking is
associated with an increased risk of myocardial irtfarc-
tion'sudd'en death and arterial thrombosis occur more
frequently in cigarette smokers.'" Because blood
platelets appear to play a central role in the initiation of
arterial thrombosis, the difference in aggregation be-
havior in platelets from smokers and non-smokers
seems to be important. The influence of nicotine andl
or other cigarette constituents on platelet function has
been investigated in several' in ciro and in t:itro
studies. From these studies it is known that smoking
induces enhancement-of platelet function." Evidence
supporting this idea includes an association of smoking
with increased ADP induced platelet aggregation in
platelet-rich plasma,' an enhanced tendency of plate-
lets to aggregate in blood;- a shortening of platelet
survival'° and' increased thromboxane synthesis.'t'' In
addition there is some evidence that smoking might
exert its action by reducing vascular prostaeyctin
(PGI,) synthesis." Since we have previously demon
strated reduced platelet sensitivity to exogenous PGI,
in vitro in patients with atherosclerosis," we wondered
whether cigarette smoking might decrease platelet
sensitivity to PGIx. Because of recent observationsts'"
that passive smoking increases the incidence of various
diseases primarily associated with active smoking, we
also wondered whether even passive smoking could
influence platelet sensitivity to PGIr. If platelet sensi-
tivity to PGI, were suppressed by active or passive
'Frvm the Second Department of Internal Medicine. University of.
Vientsa- ViennZ Austria.
Manuscript received Uctober 21.I985: tsvisbn accepted January 20.
Reprint repueru: Dr. 8u huber, Carnuongaire !3. ll' Medical
Deportnsnu. Urus:ersity of~ienna. Viersna, Auatna A1090
Ko,TuC E
thls mat°~zl' m_y be
Orotectsd by ct-~-right
law ftiUQ 17 U.S. Ccde),
after smofdng t+vo cigarettes (active smoidng) and prior to
and after exposure to a tobacco smoke-contamitsated atmo-
sphere (passive smoldng). 'lflhis sts.dy indicates tliatplatelets
of chsvnic smokers are less sensitiwe to esogeoout PGI, than
platelets of aoQ-smokers. In addition, active as well as
psssive si<uo+dng decreases plaeidet sensitivity to PCl, in
taon-smokers, whereas ebevnic smokers esbibit no further
decline. We conclude tlut decreased platelet sensitivity to
PGI,, might be an important contributing factor to the
altered platelet function observed in patients with athetv-
sdesosis.
smoking, then we could consider it an additional
important mechanism of arterial thrombosis.
MATERIAL AND METHODS
Actiec Smo/ring
The subjects of this study were 14 healthy male volunteers whose
:utes ranged fnrm38 toJ6 years. Seven were non-smokers and'seven
were moderate-to-hea.y smokers lat least one pack a day for at )east
ten vrarsl. Standard commercial brands containing 1.5 mg nicotine
and 3; m¢ tu per p,run of cipiette were used: The smokers re-
frwned from smoking for at least four hours pnor to the test
prncedures, and no mediutton was allowed for tKo weeks prior to
the .tudies. A 19 ¢autce plutic cynnulL was inserted into the
antecubital vein 15 min pnor to baseline mersurtments to avoid
repeated %enuus paunctures.,Then the patients were told to smoke
tsAn cia.rrttes, one .ftrr the other. %ithin 10 min. Immediately
hefiore And 1.5 min After smukinA t+n cip,.rettes, blood pressure,
pulse rate. and!entilstor% function teats were performed and blood
w.u drawn. Blood pressure waameasured.vith the Korotkoff inethod
bc the ume ohaer.er, lentilatorc function was assessed by spirome-
try usin¢ a Fleuch pneumuucho¢raph att.uhed to an electronic
device (Simgnost FD 10. Siemens Elemic 19) and recorded on an x-y
recorder (Hewlett-Paciurd); Vital capacity (VC. L)'was determined:
by a slow inspintory e6ort.
This was followed by three attempts of FEV; maneuvers (FEV,,, L)
After completion of these procedures, forced expiratory flow volume
curves were obtained. Forced etpiratorv flows at the moment when
50 percent of the vital capacity had been expelled (FEF Lsec) and
when 75 percent had been expelled (FEFs, L?sec) were read
ditrctly from the flow volume curves. The best-ofthnre attempts was
used for calculYtion.
Blood withdrawal was performed from the previousli inserted
plastic cannuls. Nine.olumes ofblood were miaed with one volume
of 3:8 percent trssodium citrate solution to obtmn citrated blood.
After centrifuganon at LSO g for 5 min, platelet-rieb pluma (PRP) wu
obtained. PRP was then removed and plitelet-poor plasma (PPP)
prod'uced: by further centr9fuguion of LS00 g for 15 min. PIiP was
adjusted with PPP to give a platelet count of' apprvximitely
250 x 10'lµJi ADP'(in a rather high coneentration of 1 mmoUl) was
used to cause irreversible platelet aggregation measured in a Born-
34 Pfosa.cyctn n Snds.n tna Won vnok«s reuqtwo.r W tv)

mm Hg NON SMOKER SMOKER
160,
11.0 ~
Systotlc 120
100
80
Diastolic
It
BEFORE
NS
AFTER
IZ
O
Ftcuae L Individual data points and
N.S. meansofsrstolicanddiastolicbloodpres-
sure (BP: mmHR) before and'after smok-
ing 2' cigarettes in smokers and non-
BEFORE AFTER smokers.
t.pe aggreRometer. On all otrasions. second phase of ADP-induced
platelet aggregation was seen. The maximal estent of platelet
aggregation c.YTmasl was calculated usuming that PPP was 100 per-
cent and PRP was d percent aggregation. !n addition, ADP-induced
platelet aggregation was inhibited b}- increasing concentrations of
PCh (1:2.3 ng/ml) being added 60 sec prior to ADP From this the
sensitivity index of PCI, (S1m,t) was calcullted' (Slrca, - 11ID,,;
IDb = the concentration of PGIy necessar-y to inhibit ADP-induced
piatelet aggregation to 50 percent).
Fbasiue Smoking
Another 22 healthv male volunteers. 13 smokers and nine non-
smokers. whose ages ranged from 25 to 40 ,vears, were e:posed to
cigarette smoke. Smokers refrained from active smoking for at kast
four hours before studiedl,
Volunteers were kept for 20 min in an 18 m' room in which testers
smoked 30 hea.v brand cigarettes just prior to the exposure penod.
This concentration was calculated to be that occurring in discos,
restaurants etc. Again: blood was drawn before and 15 min after the
passive s,no!Ring period and aggregation studies were performed'as
previouslY described:.
Statisti csl ',1'r!al'ysis
PairrdanJ u, pured'Student'st-testswereusedtocompateresults
HR'
beah/min
100 ~
90,
70 -~
60 ~
Ftcutu: 2. Individual data points and I
within and between groups respectivel>. Differences were consid-
ered significant when p<0.05
RESC'LTS
Active Smoking.
Prior to smoking hw cigarettes. neither smokers nor
non-smokers exhibited any difference in either systolic
or diastolic blood~ pressure (Fig 1) or in heart rate (Fig
2)! After smoking two cigarettes, blood pressure re-
mained unchanged (Fig 1), whereas a significant in-
crease in heart rate could be observed in ~ both groups
(Fig 2). There was no difference in VC and FEV, prior
to or after smoking between smokers and non-smokers
(Tablt? 1). However, smokers had lower forced ex-
piratorti 9ouw rates compared to non,smokers, before as
well as after smoking two cigarettes (Table 1). Smoking
two cigarettes did not alter antventilatory parameters
studied in either group.
Prior to smoking two cigarettes, the aggregation of
platelets in response to ADP was the same in: smokers
NON SMOKER
means of heart rate (hIR. beats/minute) ~i
~ before and after smoking 2 cigarettes in
smokers and non-smokers. BEFORE
.
/b
AFTER
pc -05
ill
BEFORE AFTER
QiEST r Yo i t i JuLr, ttas6 ]6

Lbk I-rwd'+oiidYal rsag FUwdiow Pbrosserrs bs`o.r and aRer ss.ohin6 Two eidarsttss m Now-.,.okm snd
S.wher,
VC (L)' FEV~ (L) FEF. (L/sec) FEFe (Usec)~
Non-smokers
Beiore After Before After Before After Before After
1 6,5 6.1 4.3 4.6 4.3 5.4 2.2 2:8
2 7.8 7.6 5.8' 6.2 11.4 9.4 3.7 5:3'
3 6.4 6.5 5.6 5:8 5.6 5.8 2.9 3.3'
4 5.6 5_8 3.7 4.6 5.1 4.8 2.6 2.4
5 3.5 3_6 2.8 2.7 4.3 3.5 2:4 1.4
6 4.5 4.9 4.3 3.7 5.9 5.2 4.5 4.1
7 jp 5.6 4.8 4.0 3.9 5.1 4.1 2.1 2.1
mean S
SEM
Smokers
5.7 s 0.5
5.6 z 0.5
4.3 _ 0.'4
4.5 s 0:5
6:0 = 0:9
5.5 = 0.7
2:9 z 0.3
3.1 s 0:5
1 5.3 5.5 4:11 4.6 6.2 7.3 3.7 3.9
2 6.4 6.3 5.1 4.5 5:2 5.2 2.4 2.2
3 4.6 4.7 3.2 3.5 3.9 3.1 2.7 1.4
4 6.0 6.5 4.5 4.5 5.0 4.8 2.2 2:7
5 5.8 5.7 4.2 4.2 4.7 4.5 2.6 2:1
6 3.9 4.46 2.9 2.9 3.0 2.6 1.1 1.2
7 4,.6 4_7 3.5 3.2 3.5 3.1 1.6 1.0
mean ~
SEM 5.3c0.4 5.4_0:3' 3.9_0.3 3.9_-0.3
p<0.1i
tp<0.05, smokers vs non-smokers
and' non-smokers (48 t4 percent in smokers vs 44 :t4
percent in non-smokers). However, platelet sensitivity
to PGI,, expressed'as sensitivity index to PGI was sig-
nificantly lower in smokers compared to non-smokers
(Fig 3). After smoking two cigarettes, ADF ind'uced
platelet aggregation did not change in either group
(49 _ 2 percent in smokers vs 50 !: 2 percent in non-
smokers). In contrast, the sensitivity index to PGI,
significantly decreased in non-smokers, almost reach-
ing baseline-level: for smokers (Fig 3). In smokers,
liowever, no further decrease in platelet sensitivity to
PGI, could' be observed. Thus, after smoking two ciga-
rettes, no further statistically significant difference
between smokers and non-smokers could be iound.
Phssiee Smoking
Sensitivity index to PGI, again was significantly
lower in the smoker group as compared to non-smok-
ers (Fig 4). Passive smoking in non-smokers indueed'a
SI' 1.07
PGIZ
,
0.51
.
0
M
~ER
P<AS ~ `P<.08
` SMOKER I1is
~--
BEFORE AFTER
Frcuns 3;, Sensitivky inda oEPCI, (St~'bei'ore and s[!er smok-
ing 2 cigarettes in smokers and noo-amobess.
~
4.5 x 0:4 4.3 _ 0.6 2,3 _ 01" 2.0 s 0,4Y
significant decrease in platelet sensitivity to PGI,,
whereas in smokers no further decrease could be
demonstrated.
DISCUSSION
The main finding of this study is that smokers' plate-
lets are less sensitive to the anti-aggregatory action of
exogenous PGI, compared to platelets of non-smokers.
Further, our results show that only in non-smokers
does acute inhalation of tobacco smoke decrease plate-
let sensitivity to PGI, in vitro. Finally, a decrease in
platelet sensitivity to PGI, was observed in non-smok-
ers after active as well as after passive smoking.
It is well~-established that platelet sensitivity to PGI,
is a reliable and sensitive test to examine platelet func-
tion." In , tr experiments, there were two lines of
evidence fo the reliability of this procedure. First,
platelet sensitivity to PGI, was reproducible in two dif-
I.0
Sl
PG12
P<.a
~
SMOKER ~'~ ~
,
3 ~
~.~
AFTER
N
BEFORE
FieuRE4. Sensitivity indes oEPCIs (Slrcy)'before and aRer passis r^
smoidng in smokers and non-smokers W.
36 Prc.heycM n Sma*rs ard Mbn-rfnksn (durpMuWW or so

ferent populations (eg, in 14 volunteers smoking ac-
tively and in 21 volunteers smoking passively): Second,
platelet sensitivity to PGI, was sensitive in distinguish-
ing between the platelet function,of smokers and non-
smokers. Thus, it appears that this procedure is of
additional~ value in examining platelet function in
various circumstances. However, as with other platelet
function tests, we do not know if this in vitro procedure
accurately reflects platelet function in ciuo.
We have usej a rather high concentration of ADP,
previously shown to be optimal for measurements of
platelet sensitivity to PG1,.'° Therefore our results of
ADP-induced platelet aggregation cannot be compared
with a previous stud}6 using different, lower concen-
trations of ADP. This study showe& a significant
increase of ADP ind'uced; platelet aggregation after
smoking. Nevertheless, even with the high ADP-con-
centration used in this study, there was a tendency
towards an increase in AD P-induced platelet aggrega-
tion after smoking two cigarettes in the non-smoker
group.
The influence of cigarette smoking on platelet func-
tion has been investigated in several in vitro and in L-ivo
studies.'-" Although the precise effect is not clear, in
most studies potentiation of platelet aggregation has
been observed. Our findings of a diminished platelet
sensitivity to an anti-aggregatory substance in smokers
fits into the overall idea of a proaggregatory effect of
cigarette smoking. Chronic smoking can desensitize
blood platelets to PGI,; such platelets wouldhypothet-
ically be more ready to aggregate and participate in
plug formation, leading to arterial thrombosis. Our re-
sults are thus in-agreement with the well-known clini-
cal finding of the increase& incidence of thromboem-
bolic diseases in smoken." Since causes other than
smoking could conceivably have led to a decrease in
platelet sensitivity to PGI, observed' in our smokers,
we investigated whether smoking two cigarettes v-vuld
acutely influence platelet sensitivity to PGIi,. A signifi-
cant decrease in platelet sensitivity to PGI, in non-
smokers indicated that cigarette smoking is responsi-
ble for the decreased platelet sensitivity to PGI, in
smokers.
The fact that acute smoking did not alter platelet
sensitivity to PGI, in chronic smokers remains to be
clarif,ed, One esplanation is that smoking two ciga-
rettes exhibits a much lower emotional stress in smok-
en than in non-smokers. Since platelet aggregation has
been shown to vary withemotional stress,° this could
have led to a different platelet behavior after acute
smoking. We did not measure plasma epinephrine
concentrations parallel to platelet function in this
study. However, if one compares blood pressure and
heart rate before and after smoking two cigarettes in
smokers and non-smokers, one will find: a) no statis-
tical significant changes in blood pressure, and b), a
similar, marked ~ increase in heart rate in both groups.
Despite not being statistically significant, there was an
obvious increase in systolic and diastolic blood' pres-
sure after smoking two cigarettes in the non-smoking
group (Fig 1). This increase could have reached statis-
tical significance if more patients had been studied.
Nevertheless, it seems unlikely that different adre-
nergic stimuli were responsible for the difference in
platelet behavior after acute smoking.
An alternative explanation is that acute smoking in-
fluences lung function parameters diETerently in smok-
ers and non-smokers, which could cause differences in
platelet function, Since no significant change in lung
function-could be demonstrated in either group after
smoking two cigarettes, we strongly feel that differ-
ences in lung function cannot account for the different
behavior in platelet sensitivity to PGI, after acute
smoking. It is interesting to note, however, that smok-
ers revealed lower forced expiratory flow rates at 50 and
25 percent of vital capacity compared to non-smokers
(table 1): These findings confirm previous studies" °
indicating some degree of smalli airways disease in
smokers. Finally, platelets of chronic smokers may
already, be desensitized to an extent where no further
decrease is possible, but this alternative was not
clarified.
In recent years the possible consequences to the
health of non-smokers exposed to cigarette smoke
(passive smoking) have been ezaminedl 1- It has been
shown thatpassive smoking could lead to deterioration
of lung function in adults° and children.r'" Further,
the effect! of passive smoking on the development of
lung cancer was studied epidemiologically in ]apan,"
indicating the possible importance of passive smoking
as one of the causal factors of lung cancer. To, our
knowledge, there is no evid'ence published so far, indi-
cating a higher risk of developing arterial thrombosis in
passive smokers.
In the present study of healthy male non-smokers,
we found a significant decrrase in platelet sensitivity to
PGI, after acute passive exposure to tobacco smoke.
This finding at least suggests that platelets of non-
smokers passively exposed to tobacco smoke might also
exhibit a higher tendency to aggregate. Further inves-
tigation is needed to elucidate whether this finding is
important with respect to a possible increased inci-
dence of thromboembolic disease among non-smokers
passively exposed to cigarette smoke.
In any event, the present study has suggested that
active and passive tobacco smoking is primarily re-
sponsible for a decrease in platelet sensitivity to PGI,
in vitro. Although the results obtained in vitro cannot
be directly extrapolated to in vioo situations, they may
extend our understanding of the mechanisms by which
smoking increases the risk of embolic disease.
Q£Sr rf0 r t r JuIY, two 37
